Newcastle University - New research shows treatment of a borderline low thyroid hormone level lowers cholesterol, reverses weight gain and reduces the risk factors for heart disease.纽卡斯尔大学-新的研究显示，治疗边缘低甲状腺激素水平降低胆固醇，推翻了，体重增加和减少危险因素心脏病。

Putting on weight and feeling lethargic?把重量和感受昏睡？ Then this new study shows it is worth having your thyroid levels checked – as these can be symptoms of borderline thyroid disease which is easily identified and treated.那么，这个新的研究显示，它是值得拥有你的甲状腺水平检查-因为这些活动可征状边缘甲状腺疾病是很容易发现和治疗。

Known medically as sub-clinical hypothyroidism, it is characterised by a shortage of the hormone thyroxine and often precedes an underactive thyroid.众所周知，医学上作为亚临床甲状腺功能减退症，它的特点是短缺的激素甲状腺素，而且往往先行了underactive甲状腺。 It affects up to 16% of women and 6% of men, becoming more prevalent with age.它影响到多达16 ％的妇女和百分之六的男人，变得越来越普遍，随着年龄的。

The research has shown that treatment of subclinical hypothyroidism with thyroid hormone reduces tiredness, cholesterol and reduces the risk factors for heart disease by improving the markers of atherosclerosis or hardening of the arteries.该研究显示，治疗亚临床甲状腺功能减退症与甲状腺激素减少疲劳，降低胆固醇和降低危险因素的心脏病，提高标志性动脉粥样硬化或硬化的动脉。

In the study, patients undergoing 12 weeks of thyroxine treatment saw a reduction in their amount of LDL cholesterol, reversed weight gain - losing on average half a kilo, felt less tired and had reduced their risk factors for heart disease.在这项研究中，患者接受12周的甲状腺素治疗看到了减少其数量的低密度脂蛋白胆固醇，扭转体重增加-失去平均半年基洛，觉得少累，并已减少了它们的危险因素心脏病。

Until recently many doctors considered this condition not worthy of treatment.直到最近，许多医生考虑过这个状况不值得治疗。 Now a new study led by Dr Jolanta Weaver of Newcastle University and Gateshead Health NHS Foundation Trust published in this month’s issue of The Journal of Clinical Endocrinology and Metabolism shows that treatment leads to significant improvements for patients.现在，一项新的研究博士为首jolanta维夫的纽卡斯尔大学和gateshead健康国民保健信托基金会发表在本月出版的杂志上的临床内分泌与代谢表明，治疗导致了显着的改善，为病人。

In the largest trial to date, 100 participants with persistent subclinical hypothyroidism were given thyroxine and compared with those taking a placebo or dummy medication.在最大的审判日期， 100名与会者与持久性亚临床甲状腺功能低下者给予甲状腺素治疗，并与服用安慰剂或假服药。

Dr Salman Razvi and Dr Jolanta Weaver of Newcastle University’s School of Clinical Medical Sciences carried out a pivotal crossover study.博士萨勒曼拉兹维博士jolanta维夫的纽卡斯尔大学医学院临床医学科学进行了一场关键的交叉研究。 They assessed common heart disease risk factors such as the level of LDL, or “bad”, cholesterol, body weight and endothelial function, which is a very early marker of hardening of the arteries.他们共同分摊心脏病的危险因素，如水平低密度脂蛋白或"坏"胆固醇，体重及血管内皮功能，这是一个非常早期的标志物硬化的动脉。 They also asked participants to rate their quality of life.他们还要求与会者率他们的生活质量。

This treatment did not cause any side-effects.这种治疗没有造成任何副作用。

One patient, Frances King, age 56 said, “I took part in the study because I was first diagnosed with a borderline underactive thyroid 27 years ago but never had any treatment.其中一名病人，法兰西国王， 56岁说： "我参加了学习，因为我是第一次被诊断出同一种边缘underactive甲状腺27年来，但从未有过任何治疗。 I‘d never been ill but always had a lack of energy and generally felt tired and lethargic.我从来没有受到虐待，但始终有一个缺乏能源和普遍感到疲倦和软弱无力。 As soon as I was put on the medication I noticed a difference.尽快正如我已提上了药我注意到有差别。 Since the trial I’ve been back to my GP and have been prescribed thyroxine.自从审判我已经回到我的家庭医生，并已订明甲状腺素。 I now have more energy and feel brighter.我现在有更多的精力和感觉更加明亮。

I’ve battled with my weight for years but since getting the medication I’ve lost a couple of stones because I’m more motivated to do things.我已经战斗与我的体重多年，但由于越来越吃药，我已经一无所有了一对夫妇的石头，因为我更主动地做一些事。 I’ve got a real zest for life - I run up the stairs, I’ve got the energy to walk the dogs and I’m out gardening which I hadn’t been doing.”我还有真正的热情人生-我运行了楼梯，我有了能量才能走路狗，我出来园艺当时我没有做" 。

Dr Weaver says, “The results of our study show that treatment of people with this mild form of underactive thyroid condition leads to significant improvements in risk factors for ischemic heart disease and symptoms of tiredness.”博士维夫说， "研究结果显示，治疗的人，这个温和的形式underactive甲状腺状态，导致显着的改善危险因素缺血性心脏病症状的疲倦" 。

Patients with subclinical hypothyroidism are being encouraged to discuss their treatment with their doctors to see if they can improve cholesterol, weight control, and heart disease risk.亚临床甲状腺功能减退受到鼓励，讨论他们的待遇与他们的医生，看看是否可以改善胆固醇，控制体重，和心脏病的风险。